EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer

Yue Pan, Hui Yu, Feng Lu iD

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231178639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Yue Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Tripartite motif-containing protein 11 (TRIM11), an E3 ubiquitin ligase, possesses a pro-tumor property. Still, the detailed functions of TRIM11 remain not well characterized in prostate cancer.

Methods

PC-3 and DU145 prostate cancer cells were transfected with small interfering RNAs (siRNAs) or lentiviruses for TRIM11 deficiency or overexpression, and microRNA-5193 (miR-5193) mimics were utilized for overexpressing miR-5193. Proliferation, apoptosis, migration, and invasion were examined through CCK-8, colony formation, flow cytometry, wound healing, and transwell assays. MAP kinase-extracellular signal-regulated kinase (MEK1/2) and extracellular signal-regulated kinase (ERK)1/2 activities were detected via immunoblotting. Murine xenograft models were established. Interactions of TRIM11 with miR-5193 were demonstrated via dual luciferase reporter.

Results

TRIM11 deficiency or miR-5193 overexpression exerted antiprostate cancer effects through suppression of proliferation, migration, and invasion as well as enhancement of apoptosis in PC-3 and DU145 cells. The mechanisms by which TRIM11 deficiency or miR-5193 overexpression involved the inactivation of MEK1/2 and ERK1/2. miR-5193 downregulated TRIM11 expressions in prostate cancer cells, and their interactions were confirmed. Further, up-regulated miR-5193 weakened the effects of TRIM11 overexpression on enhancing proliferation, migration, invasion, and activity of MEK1/2 and ERK1/2 as well as alleviating apoptosis of prostate cancer cells. In murine xenograft models, TRIM11 upregulation facilitated tumor growth, which was alleviated by miR-5193 overexpression.

Conclusion

These findings described the oncogenic role of TRIM11 in prostate cancer biology, which was post-transcriptionally modulated by miR-5193.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMicroRNAsMaleHumansAnimalsMiceCell Line, TumorCell ProliferationRNA, Small InterferingExtracellular Signal-Regulated MAP KinasesCell MovementGene Expression Regulation, NeoplasticApoptosisTripartite Motif ProteinsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

TRIM11metastasismiR-5193proliferationprostate cancer

Substanzen

RNA, Small InterferingExtracellular Signal-Regulated MAP KinasesMicroRNAsTRIM11 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesMIRN5193 microRNA, human

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, China.

ORCID-Profile: Feng Lu

Zitieren

APA

Pan, Y., Yu, H., & Lu, F. (2023). TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231178639

Vancouver

Pan Y, Yu H, Lu F. TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231178639

BibTeX
@article{Pan2023,
  author = {Pan, Yue and Yu, Hui and Lu, Feng},
  title = {TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231178639}
}
Kostenlos starten →